Medivolve Inc MEDVF

Healthcare Copper

Medivolve, Inc. is a Canada-based healthcare technology company. The Company has two business units: Medivolve Pharmacy Division (MPD) and Collection Sites Diagnostics (CSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine, and psychiatry to patients in Southern California. CSD’s software platform, Electronic Health Records app (EHR), is focused on supporting clinical staff, is a series of assets and functionalities that enhance the customer experience and provide an end-to-end lab solution. The Company, through its subsidiaries, Medivolve Pharmacy Inc., and Kedy Ying Jao D.O., a medical corporation, operate a distributed network of two retail patient-care locations in California, United States. The Company has served hundreds of thousands of patients across the United States and facilitated more than 1,533,000 clinical tests.

OTCPK:MEDVF - Post by User

Medivolve Inc

<< Previous

Bullboard Posts

Next >>

Post by Hiddensecretson Jan 08, 2021 8:14pm

112 Views

Post# 32259896

WHO approves delaying 2nd dose by 6 weeks.....

World Health Organization experts have issued recommendations saying that the interval between administration of two doses of the Pfizer-BioNTech vaccine can be extended to up to six weeks.

WHO’s Strategic Advisory Group of Experts on immunization, known as SAGE, formally published guidance Friday saying that an interval of 21 to 28 days between the first and second doses is recommended.

https://www.newsmax.com/world/globaltalk/who-covid-shots-vaccine/2021/01/08/id/1004754/

My personal comments:

Pfizer said, that vaccine is ineffective after 21 days of receiving 1st dose. WHO recommends 2nd dose in 6 weeks and not 21 days.

Pfizer said there is NO EVIDENCE that vaccine administered later than the 21 day period is effective.

I guess WHO does not want virus to go away.

MPO